This trial is conducted in Europe and the United States of America (USA). The aim of this
trial is to compare the efficacy and safety of NN1250 (insulin degludec (IDeg)) once daily in
insulin naïve subjects with type 2 diabetes mellitus when titrated using two different
self-titration algorithms (dose individually adjusted) in combination with metformin.